Amryt Pharma plc
AMYT
Depository Receipt
$14.70
Sector: Health Care
Industry: Pharmaceuticals
Sub-Industry: Pharmaceuticals
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | $0.00 | -$0.66 | -$0.83 | -$0.11 | -$0.13 |
Sales/Revenue | $222.54 M | $182.61 M | $58.12 M | $17.05 M | $14.41 M |
Sales Growth | 21.87% | 214.17% | 240.86% | 18.31% | 0.00% |
Gross Margin | +53.73 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | $1.00 M | -$104.53 M | -$63.00 M | -$30.41 M | -$29.48 M |
Net Income Growth | 100.96% | -65.92% | -107.16% | -3.16% | 0.00% |
Net Margin | +0.45 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | $29.10 M | -$0.98 M | -$20.49 M | -$17.63 M | -$15.75 M |
Cost of Goods Sold (incl D&A) | $102.98 M | $116.87 M | $36.18 M | $4.69 M | $4.65 M |
Cost of Goods Sold (excl D&A) | $52.24 M | $72.41 M | $23.90 M | $4.32 M | $4.36 M |
Cost of Goods Growth | -11.88% | 223.04% | 671.47% | 0.89% | 0.00% |
Research & Development | $37.73 M | $27.62 M | $15.83 M | $10.68 M | $11.92 M |
Other SG&A Expenses | $0.00 M | $65.16 M | $30.49 M | $14.76 M | $10.78 M |
Interest Expense | $27.91 M | $19.57 M | $4.76 M | $1.62 M | $0.95 M |
Income Tax | -$7.56 M | -$1.33 M | -$0.50 M | $0.04 M | $0.00 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.05 | $0.07 | -$0.07 | -$0.04 |
Sales/Revenue | $59.13 M | $54.83 M | $56.52 M | $62.76 M |
Sales Growth | 7.84% | -2.99% | -9.95% | 29.59% |
Gross Margin | +53.73 | 0.00 | 0.00 | 0.00 |
Net Income | -$14.49 M | $22.37 M | -$17.21 M | -$6.80 M |
Net Income Growth | -164.77% | 230.01% | -153.11% | 58.89% |
Net Margin | +0.45 | 0.00 | 0.00 | 0.00 |
EBITDA | $2.45 M | -$0.12 M | $3.02 M | $15.09 M |
Cost of Goods Sold (incl D&A) | $30.78 M | $29.19 M | $27.27 M | $26.18 M |
Cost of Goods Sold (excl D&A) | $15.95 M | $13.68 M | $14.11 M | $15.16 M |
Cost of Goods Growth | 5.44% | 7.05% | 4.15% | 11.45% |
Research & Development | $9.88 M | $9.28 M | $11.00 M | $8.54 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $20.61 M | $17.15 M |
Interest Expense | $11.13 M | $7.74 M | $6.42 M | $5.84 M |
Income Tax | -$10.53 M | $3.09 M | -$15.53 M | $0.19 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $7.42 M | $7.57 M | $3.04 M | $1.10 M | $1.39 M |
Cash and Short-Term Investment | $113.03 M | $118.80 M | $67.23 M | $11.22 M | $24.63 M |
Cash and Short-Term Investment Growth | -4.85% | 76.71% | 499.43% | -54.47% | 0.00% |
Long Term Debt | $203.23 M | $192.96 M | $179.52 M | $17.15 M | $12.73 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $816.06 M | $536.59 M | $527.10 M | $80.76 M | $96.17 M |
Total Assets Growth | 52.08% | 1.80% | 552.71% | -16.03% | 0.00% |
Inventories | $115.77 M | $40.99 M | $58.00 M | $2.14 M | $1.30 M |
Finished Goods | $65.93 M | $11.63 M | $35.47 M | $1.05 M | $0.39 M |
Short Term Debt | $1.55 M | $0.96 M | $0.57 M | $0.00 M | $0.00 M |
Total Liabilities | $459.40 M | $470.45 M | $395.26 M | $84.45 M | $69.89 M |
2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $7.11 M | $7.42 M | $8.40 M | $7.22 M | $7.16 M |
Cash and Short-Term Investment | $102.22 M | $113.03 M | $123.18 M | $142.95 M | $118.55 M |
Cash and Short-Term Investment Growth | -9.57% | -8.24% | -13.83% | 20.58% | 0.00% |
Long Term Debt | $209.38 M | $203.23 M | $200.60 M | $198.01 M | $195.34 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $786.87 M | $816.06 M | $855.46 M | $533.66 M | $521.97 M |
Total Assets Growth | -3.58% | -4.61% | 60.30% | 2.24% | 0.00% |
Inventories | $120.06 M | $115.77 M | $100.84 M | $38.76 M | $39.37 M |
Finished Goods | $69.87 M | $65.93 M | $39.83 M | $0.00 M | $0.00 M |
Short Term Debt | $0.96 M | $1.55 M | $1.53 M | $0.95 M | $0.97 M |
Total Liabilities | $440.89 M | $459.40 M | $549.44 M | $484.35 M | $467.61 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|
Quarter | Amount | Yield |
---|
|
|